VAXDIGM

Private

SeoulEnterprise Softwarehttps://vaxdigm.com/

Last Round

Grant

May 20, 2026

Total Funding Raised

$3.98M

Company Overview

VAXDIGM is a biotechnology company that develops innovative vaccines using its proprietary CHAPERNA (Chaperone + RNA) platform technology.

Sector

Enterprise Software

Verticals

Workflow Automation, Project Management

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

vaccine developmentbiotechnologyprotein engineeringsynthetic antigenbiomaterialsbiotech startupresearch and developmentR&Dmicrobial protein productioninfectious disease researchdrug discoverybiopharmagovernment research grantsvaccine platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VAXDIGM Comparables

Compare VAXDIGM with similar companies based on industry and business-model similarity.

VAXDIGM comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

VAXDIGM Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 20, 2026
Grant	Dec 1, 2025
Series A	Oct 24, 2024
Pre Seed	Aug 1, 2023
Seed	May 1, 2022

View all Funding Rounds

VAXDIGM Investors

Notable investors and investment history

VAXDIGM investors
Investor	Rounds
Korea Alternative Investment Asset Management	Series A
Infobank Corp	Series A
The Invention Lab	Series A
LITALCO	Series A
New Paradigm Investment	Series A

View all Investors

VAXDIGM Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VAXDIGM Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VAXDIGM's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range3

Year Founded2021

Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.